X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.488
-0.001 (-0.29%)
Jan 22, 2025, 4:00 PM EST - Market closed
X4 Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 83 | 140 | 121 | 64 | 105 | 172 | |
| Market Cap Growth | -37.07% | 16.23% | 87.36% | -38.49% | -39.22% | - | |
| Enterprise Value | 26 | 57 | 79 | 28 | 47 | 119 | |
| Last Close Price | 0.49 | 0.84 | 0.99 | 2.29 | 6.43 | 10.70 | |
| PS Ratio | 87.19 | - | - | - | 34.91 | - | |
| PB Ratio | 1.38 | 2.75 | 1.63 | 1.00 | 1.44 | 1.33 | |
| P/TBV Ratio | 3.52 | 4.16 | 2.13 | 1.37 | 2.29 | 1.69 | |
| EV/Sales Ratio | 23.43 | - | - | - | 15.63 | - | |
| Debt / Equity Ratio | 1.31 | 1.14 | 0.52 | 0.62 | 0.53 | 0.18 | |
| Asset Turnover | 0.01 | - | - | - | 0.02 | - | |
| Quick Ratio | 4.65 | 5.02 | 5.50 | 5.89 | 6.66 | 13.57 | |
| Current Ratio | 4.89 | 5.34 | 5.76 | 6.27 | 6.97 | 13.68 | |
| Return on Equity (ROE) | -26.35% | -161.67% | -135.58% | -129.28% | -61.51% | -86.74% | |
| Return on Assets (ROA) | -46.55% | -44.38% | -40.36% | -39.24% | -26.39% | -35.02% | |
| Return on Capital (ROIC) | -62.04% | -60.58% | -50.81% | -43.72% | -28.42% | -38.68% | |
| Earnings Yield | -20.17% | -72.12% | -77.78% | -137.70% | -59.33% | -30.65% | |
| FCF Yield | -151.61% | -68.85% | -63.97% | -111.04% | -57.47% | -27.99% | |
| Buyback Yield / Dilution | -30.46% | -179.91% | -146.71% | -28.25% | -74.13% | -2411.98% | |
| Total Shareholder Return | -30.46% | -179.91% | -146.71% | -28.25% | -74.13% | -2411.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.